U.S. Senate Report Highlights Medicaid Drug Pricing Loophole that 340B Experts Warn Could Affect Provider Savings
A recent U.S. Senate report found that a U.K.-based pharmaceutical giant used a loophole to reap profits and avoid Medicaid [...]
